NF-kappaB P50/P65 hetero-dimer mediates differential regulation of CD166/ALCAM expression via interaction with micoRNA-9 after serum deprivation, providing evidence for a novel negative auto-regulatory loop

Nucleic Acids Research

Volumn 39, Issue 15, 2011, Pages 6440-6455

  Wang, Jiayi ^a   Gu, Zhidong ^a   Ni, Peihua ^b   Qiao, Yongxia ^c   Chen, Changqiang ^a   Liu, Xiangfan ^a,b   Lin, Jiafei ^a   Chen, Ning ^b   Fan, Qishi ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c TONGJI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; HETERODIMER; I KAPPA B ALPHA; MESSENGER RNA; MICRORNA; MICRORNA 9; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MIRN9 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ARTICLE; AUTOREGULATION; CD166 GENE; CELL MIGRATION; CELL NUCLEUS; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEPATOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION INITIATION SITE; UPREGULATION; BIOSYNTHESIS; CELL MOTION; CULTURE MEDIUM; DIMERIZATION; ENHANCER REGION; FEEDBACK SYSTEM; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; TUMOR CELL LINE;

ACTIVATED-LEUKOCYTE CELL ADHESION MOLECULE; CELL LINE, TUMOR; CELL MOVEMENT; CULTURE MEDIA, SERUM-FREE; DIMERIZATION; ENHANCER ELEMENTS, GENETIC; FEEDBACK, PHYSIOLOGICAL; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; NF-KAPPA B P50 SUBUNIT; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; TRANSCRIPTION FACTOR RELA; UP-REGULATION;

EID: 80055072052     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkr302     Document Type: Article

References (45)

1. Degen, W.G., van Kempen, L.C., Gijzen, E.G., van Groningen, J.J., van Kooyk, Y., Bloemers, H.P. and Swart, G.W. (1998) MEMD, a new cell adhesion molecule in metastasizing human melanoma cell lines, is identical to ALCAM (activated leukocyte cell adhesion molecule). Am. J. Pathol., 152, 805-813. (Pubitemid 28110727)
2. Bowen, M.A., Patel, D.D., Li, X., Modrell, B., Malacko, A.R., Wang, W.C., Marquardt, H., Neubauer, M., Pesando, J.M., Francke, U. et al. (1995) Cloning, mapping and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand. J. Exp. Med., 18, 2213-2220.
3. Ohneda, O., Ohneda, K., Arai, F., Lee, J., Miyamoto, T., Fukushima, Y., Dowbenko, D., Lasky, L.A. and Suda, T. (2001) ALCAM (CD166): its role in hematopoetic and endothelial development. Blood, 98, 2134-2142.
4. Arai, F., Ohneda, O., Miyamoto, T., Zhang, X.Q. and Suda, T. (2002) Mesenchymal stem wells in perichondrium express Activated Leukocyte Cell Adhesion Molecule and participate in bone marrow formation. J. Exp. Med., 195, 1549-1563. (Pubitemid 34666069)
5. van Kempen, L.C.L.T., Nelissen, J.M.D.T., Degen, W.G.J., Torensma, R., Weidle, U.H., Bloemers, H.P.J., Figdor, C.G. and Swart, G.W.M. (2001) Molecular basis for the homophilic Activated Leukocyte Cell Adhesion Molecule (ALCAM)-ALCAM interaction. J. Biol. Chem., 276, 25783-25790.
6. van Kempen, L.C.L.T., van den Oord, J.J., van Muijen, G.N.P., Weidle, U.H., Bloemers, H.P.J. and Swart, G.W.M. (2000) Activated Leukocyte Cell Adhesion Molecule/CD166, a marker of tumor progression in primary malignant melanoma of the skin. Am. J. Pathol., 156, 769-774. (Pubitemid 30626933)
7. van Kempen, L.C., Meier, F., Egeblad, M., Kersten-Niessen, M.J.F., Garbe, C., Weidle, U.H., van Muijen, G.N.P., Herlyn, M., Bloemers, H.P.J. and Swart, G.W.M. (2004) Truncation of activated leukocyte cell adhesion molecule: a gateway to melanoma metastasis. J. Invest. Dermatol., 122, 1293-1301. (Pubitemid 38651106)
8. Kristiansen, G., Pilarsky, C., Wissmann, C., Stephan, C., Weissbach, L., Loy, V., Loening, S., Dietel, M. and Rosenthal, A. (2003) ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesions. Prostate, 54, 34-43. (Pubitemid 36043834)
9. King, J.A., Ofori-Acquah, S., Stevens, T., Al-Mehdi, A.B., Fodstad, O. and Jiang, W.G. (2004) Activated leukocyte cell adhesion molecule in breast cancer: prognostic indicator. Breast Cancer Res., 6, 78-87.
10. Ikeda, K. and Quertermous, T. (2004) Molecular isolation and characterization of a soluble isoform of activated leukocyte cell adhesion molecule that modulates endothelial cell function. J. Biol. Chem., 279, 55315-55323. (Pubitemid 40066529)
11. Jezierska, A., Matysiak, W. and Motyl, T. (2006) ALCAM/CD166 protects breast cancer cells against apoptosis and autophagy. Med. Sci. Monit., 12, BR263-BR273. (Pubitemid 44186369)
12. Scott, F.L., Deanault, J.B., Riedl, S.J., Shinb, H., Renatusc, M. and Salvesen, G.S. (2005) XIAP inhibits caspase-3 and -7 using two binding sites: evolutionarily conserved echanism of IAPs. EMBO J., 24, 645-655. (Pubitemid 40343265)
13. Bursh, W. (2001) The autophagosomal-lysosomal compartment in programmed cell death. Cell. Death. Differ., 8, 569-581.
14. Zhu, W., Chen, J., Cong, X., Hu, S. and Chen, X. (2006) Hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells. Stem Cell, 24, 416-425. (Pubitemid 44464811)
15. Wei, J., Sun, Z., Chen, Q. and Gu, J. (2006) Serum deprivation induced apoptosis in macrophage is mediated by autocrine secretion of type I IFNs. Apoptosis, 11, 545-554.
16. Takeuchi, H., Kondo, Y., Fujiwara, K., Kanzawa, T., Aoki, H., Mills, G.B. and Kondo, S. (2005) Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitors. Cancer Res., 65, 3336-3346. (Pubitemid 40524618)
17. Mizushima, N. (2007) Autophagy: process and function. Genes Dev., 21, 2861-2873. (Pubitemid 350133435)
18. Wang, J., Liu, X., Ni, P., Gu, Z. and Fan, Q. (2010) SP1 is required for basal activation and chromatin accessibility of CD151 promoter in liver cancer cells. Biochem. Biophys. Res. Commun., 393, 291-296.
19. Rao, S., Procko, E. and Shannon, M.F. (2001) Chromatin remodeling, measured by a novel real-time polymerase chain reaction assay, across the proximal promoter region of the IL-2 gene. J. Immunol., 167, 4494-4503. (Pubitemid 32954327)
20. Wang, J., Liu, X., Wu, H., Ni, P., Gu, Z., Qiao, Y., Chen, N., Sun, F. and Fan, Q. (2010) CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res., 38, 5366-5383.
21. Xue, X., Sun, J., Zhang, Q., Wang, Z., Huang, Y. and Pan, W. (2008) Identification and characterization of novel microRNAs from Schistosoma japonicum. PLoS ONE, 3, e4034.
22. Hurteau, G.J., Carlson, J.A., Spivack, S.D. and Brock, G.J. (2007) Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin. Cancer Res., 67, 7972-7976. (Pubitemid 47395127)
23. Sun, F.Y., Chen, Q.Y., Yang, S.H., Pan, Q.H., Ma, J., Wan, Y., Chang, C.H. and Hong, A. (2009) Remodeling of chromatin structure within the promoter is important for bmp-2-induced fgfr3 expression. Nucleic Acids Res., 37, 3897-3391.
24. Carter, M.S., Doskow, J., Morris, P., Li, S., Nhim, R.P., Sandstedt, S. and Wilkinson, M.F. (1995) A regulatory mechanism that detects premature nonsense codons in T-cell receptor transcripts in vivo is reversed by protein synthesis inhibitors in vitro. J. Biol. Chem., 270, 28995-29003.
25. Matsusaka, T., Fujikawa, K., Nishio, Y., Mukaida, N., Matsushima, K., Kishimoto, T. and Akira, S. (1993) Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc. Natl Acad. Sci. USA, 90, 10193-10197. (Pubitemid 23328278)
26. Simeonova, P.P. and Luster, M.I. (1996) Asbestos induction of nuclear transcription factors and interleukin 8 gene regulation. Am. J. Respir. Cell. Mol. Biol., 15, 787-795. (Pubitemid 126441452)
27. Fraser, D.A., Arora, M., Bohlson, S.S., Lozano, E. and Tenner, A.J. (2007) Generation of inhibitory NFkappaB complexes and phosphorylated cAMP response element-binding protein correlates with the anti-inflammatory activity of complement protein C1q in human monocytes. J. Biol. Chem., 282, 7360-7367. (Pubitemid 47093689)
28. Masedunskasa, A., King, J.A., Tana, F., Cochrana, R., Stevens, T., Sviridove, D. and Ofori-Acquaha, S.F. (2006) Activated leukocyte cell adhesion molecule is a component of the endothelial junction involved in transendothelial monocyte migration. FEBS Lett., 580, 2637-2645.
29. Ghaemmaghami, S., Huh, W.K., Bower, K., Howson, R.W., Belle, A., Dephoure, N., O'Shea, E.K. and Weissman, J.S. (2003) Global analysis of protein expression in yeast. Nature, 425, 737-741. (Pubitemid 37314318)
30. Ambros, V. (2004) The functions of animal microRNAs. Nature, 431, 350-355. (Pubitemid 39265675)
31. Brennecke, J., Stark, A., Russell, R.B. and Cohen, S.M. (2005) Principles of MicroRNA-Target Recognition. PLoS Biol., 3, e85.
32. Xiao, J., Luo, X.B., Lin, H.X., Zhang, Y., Lu, Y., Wang, N., Zhang, Y.Q., Yang, B.F. and Wang, Z.G. (2007) MicroRNA miR-133 represses HERG K+ channel expression contributing to QT prolongation in diabetic hearts. J. Biol. Chem., 282, 12363-12367. (Pubitemid 47100573)
33. Mori, N., Yamada, Y., Ikeda, S., Yamasaki, Y., Tsukasaki, K., Tanaka, Y., Tomonaga, M., Yamamoto, N. and Fujii, M. (2002) Bay 11-7082 inhibits transcription factor NF-kB and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells. Blood, 100, 1828-1834. (Pubitemid 34925163)
34. Smith, C.L. and Hager, G.L. (1997) Transcriptional regulation of mammalian genes in vivo. J. Biol. Chem., 272, 27493-27496. (Pubitemid 27473531)
35. King, J.A., Tan, F., Mbeunkui, F., Chambers, Z., Cantrell, S., Chen, H., Alvarez, D., Shevde, L.A. and Ofori-Acquah, S.F. (2010) Mechanisms of transcriptional regulation and prognostic significance of activated leukocyte cell adhesion molecule in cancer. Mol. Cancer, 9, 266.
36. Bazzonia, F., Rossatoa, M., Fabbrib, M., Gaudiosib, D., Mirolob, M., Morib, L., Tamassiaa, N., Mantovanib, A., Cassatellaa, M.A. and Locatib, M. (2009) Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals. Proc. Natl Acad. Sci. USA, 106, 5282-5287.
37. Karin, M., Cao, Y., Greten, F.R. and Li, Z.W. (2002) NF-kappaB in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer, 2, 301-310. (Pubitemid 37328783)
38. Ryo, A., Suizu, F., Yoshida, Y., Perrem, K., Liou, Y.C., Wulf, G., Rottape, R., Yamaoka, S. and Lu, K.P. (2003) Regulation of NF-κB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Mol. Cell, 12, 1413-1426. (Pubitemid 38037011)
39. Nihira, K., Ando, Y., Yamaguchi, T., Kagami, Y., Miki, Y. and Yoshida, K. (2010) Pim-1 controls NF-kB signalling by stabilizing RelA/p65. Cell. Death Differ., 17, 689-698.
40. Brightbill, H.D., Plevy, S.E., Modlin, R.L. and Smale, S.T. (2000) A prominent role for Sp1 during lipopolysaccharide-mediated induction of the IL-10 promoter in macrophages. J. Immunol., 164, 1940-1951. (Pubitemid 30108749)
41. Peterson, C.L. and Workman, J.L. (2000) Promoter targeting and chromatin remodeling by the SWI/SNF complex. Curr. Opin. Genet. Dev., 10, 187-192. (Pubitemid 30182252)
42. Hassan, A.H., Neely, K.E., Vignali, M., Reese, J.C. and Workman, J.L. (2001) Promoter targeting of chromatin-modifying complexes. Front Biosci., 6, D1054-D1064.
43. Coisy-Quivy, M., Disson, O., Roure, V., Muchardt, C., Blanchard, J.M. and Dantonel, J.C. (2006) Role for Brm in cell growth control. Cancer Res., 66, 5069-5076. (Pubitemid 43844928)
44. Lee, K.Y., Ito, K., Hayashi, R., Jazrawi, E.P., Barnes, P.J. and Adcock, I.M. (2006) NF-kappaB and activator protein 1 response elements and the role of histone modifications in IL-1beta-induced TGF-beta1 gene transcription. J. Immunol., 176, 603-615. (Pubitemid 43023309)
45. Aurora, A.B., Biyashev, D., Mirochnik, Y., Zaichuk, T.A., Saánchez-Martinez, C., Renault, M.A., Losordo, D. and Volpert, O.V. (2010) NF-kappaB balances vascular regression and angiogenesis via chromatin remodeling and NFAT displacement. Blood, 116, 475-484.